We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Therapeutic Antibodies

This page provides educational resources, events, news and products related to therapeutic antibodies. Content will cover aspects from developing, purifying and testing antibodies and antibody–drug conjugates as therapeutics to their mechanisms of action in the conditions they treat.

Therapeutic Antibodies – Highlights

Therapeutic Antibodies content piece image

Therapeutic Antibodies

In this infographic, we explore the pipeline of therapeutic antibody discovery, development and manufacturing, highlighting key advancements throughout.

Therapeutic Antibody Engineering: Past, Present and Future

Download this free listicle to learn more about the current scope and future prospects for therapeutic antibody engineering.

Major Milestones in Therapeutic Antibody Engineering

In this up-to-date list of milestones in therapeutic antibody engineering, you can learn about the first FDA-approved therapeutic antibody, the discovery of phage display libraries, bispecific antibodies and more.

Recent Advances in Therapeutic Antibody Screening

This article explores the various screening technologies used in the development of therapeutic antibodies and outlines the recent advances in this area.

The Therapeutic Antibody Revolution

A crucial component of our immune system, antibodies are now the most rapidly growing class of approved biopharmaceutical drugs. We explore the past, present and future of therapeutic monoclonal antibodies.

Therapeutic Antibodies – News and Features

Breast Cancer Drug's Efficacy Can Be Restored After Resistance

Researchers have shown that targeting a protein called TACC3 (transforming acidic coiled-coil containing protein 3) can restore the effectiveness of the breast cancer drug T-DM1 if the cancer cells have developed resistance.

Cell-to-Cell Communication in Cancer

We typically think of a cancerous tumor as a bunch of abnormal cells gone rogue, but the situation is more complicated. This article will explore cell-to-cell communication’s role in cancer development, its influence on metastasis and how research is expanding our knowledge of the disease.

Breakthrough for Breast Cancer Bone Metastases

A promising new immunological pathway that could be used to treat breast cancer that has metastasized to bone has been identified.

Previously Unknown Immune Evasion Regulator in Tumors Identified

Northwestern Medicine investigators have identified a previously unknown regulator of tumor immune evasion, which may help improve the efficacy of current and future anti-tumor immunotherapies.

A Step Closer to Triple-Negative Breast Cancer Precision Therapy

New research has identified three subgroups of triple-negative breast cancer patients, based on how the tumor responds to therapy. This could enable clinicians to employ aggressive treatments only when needed.

Cancer Cell “Memories” May Lead to Improved Lung Cancer Treatments

Research shows that some lung cancer cells retain a “memory” of the healthy cell where they came from — one that might be exploited to make an emerging type of lung cancer treatment called KRAS inhibition more effective.

Therapeutic Antibodies – Multimedia

Safety Considerations for the Development of Antibody Drug Conjugates

Safety Considerations for the Development of Antibody Drug Conjugates

Purification Solutions for Therapeutic Antibodies

Tailored Purification Tools for Different Antibody Modalities

Biopharma Analysis Image

Biopharma Analysis

Therapeutic Antibodies – Webinars and Online Events

Refyen

Advancing mAb Stability Studies With Mass Photometry

SCIEX - Antibodies

Characterization of Sequence Modifications in Monoclonal Antibodies

Novel Therapeutics

Novel Purification Approaches To Streamline Manufacturing of Antibody-Based Therapeutics

Related Products

A scientist in a lab.

Lonza Delivers Solid 2023 Performance With 10.9% Cer Sales Growth and 29.8% Core EBITDA Margin

Automated Epitope Binning in a Single Assay

Lonza Announces New Filling Line for Commercial Supply of Antibody-Drug Conjugates for a Dedicated Customer

Lonza Further Extends Collaboration With Major Biopharmaceutical Partner for Manufacturing Antibody-Drug Conjugates

Comprehensive Solutions for In Vitro Efficacy Evaluation

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter